Associate Sponsors

Co-sponsor

SMS Pharma, Orchid Pharma, ITI among 9 stocks frozen in 20% upper circuit

Maker Laboratories, Gokaldas Exports, Tarmat, Palred Technologies, Viceroy Hotels and Bhagiradha Chemicals too locked in upper circuit of 20% on BSE.

markets, stocks, sensex, nifty, bse, nse
Photo: Shutterstock
SI Reporter Mumbai
Last Updated : Sep 21 2017 | 3:50 PM IST
SMS Pharmaceuticals, Orchid Pharma, Maker Laboratories, ITI and Gokaldas Exports are among 9 stocks that have frozen in 20% upper circuit on BSE in an otherwise weak market.

Tarmat, Palred Technologies, Viceroy Hotels and Bhagiradha Chemicals & Industries were too locked in their maximum limit of 20% on Thursday.

Orchid Pharma zooms 20% to Rs 21.45 on BSE on back heavy volumes after the company said it has received an EIR report from USFDA on the successful inspection of the active pharmaceutical (API) manufacturing facility in Tamil Nadu. This facility was inspected by USFDA in May 2017.

Bhagiradha Chemicals & Industries has locked in upper circuit for the second straight day, up 20% at Rs 291 on BSE ahead of its board meeting on Friday, September 22, to consider fund raising plan.

“A meeting of the board of directors of the company will be held on September 22, 2017 to consider and approve, raising of funds by way of issue of convertible warrants and equity shares on preferential basis,” Bhagiradha Chemicals & Industries said in a BSE filing.

ITI surges 20% to Rs 122, also its 52-week high on BSE, after the company announced that the company has been declared as the lowest (L1) bidder for the contract value of Rs 7,000 crore.

“The company has been declared as L1 in the “ASCON Phase IV Project” by Ministry of Defence. The contract value of the project is approximately Rs 7,000 crore,” ITI said in a BSE filing.

Security Name Group LTP Chg % Chg
MAKERSL XD 90.95 15.15 19.99
ITI B 122.20 20.35 19.98
GOKEX B 114.15 19.00 19.97
VICEROY B 21.70 3.60 19.89

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story